Literature DB >> 932197

Hereditary deficiency of the fifth component of complement in man. I. Clinical, immunochemical, and family studies.

S I Rosenfeld, M E Kelly, J P Leddy.   

Abstract

The first recognized human kindred with hereditary deficiency of the fifth component of complement (C5) is described. The proband, a 20-year-old black female with systemic lupus erythematosus since age 11, lacked serum hemolytic complement activity, even during remission. C5 was undetectable in her serum by both immunodiffusion and hemolytic assays. Other complement components were normal during remission of lupus, but C1, C4, C2, and C3 levels fell during exacerbations. A younger half-sister, who had no underlying disease, was also found to lack immunochemically detectable C5. By hemolytic assay, she exhibited 1-2% of the normal serum C5 level and normal concentrations of other complement components. C5 levels of other family members were either normal or approximately half-normal, consistent with autosomal codominant inheritance of the gene determining C5 deficiency. Normal hemolytic titers were restored to both homozygous C5-deficient (C5D) sera by addition of highly purified human C5. In specific C5 titrations, however, it was noted that when limited amounts of C5 were assayed in the presence of low dilutions of either C5D serum, curving rather than linear dose-response plots were consistently obtained, suggesting some inhibitory effect. Further studies suggested that low dilutions of C5D serum contain a factor (or factors) interfering at some step in the hemolytic assay of C5, rather than a true C5 inhibitor or inactivator. Of clinical interest are (a) the documentation of membranous glomerulonephritis, vasculitis, and arthritis in an individual lacking C5 (and its biologic functions), and (b) a remarkable propensity to bacterial infections in the proband, even during periods of low-dose or alternate-day corticosteroid therapy. Other observations indicate that the C5D state is compatible with normal coagulation function and the capacity to mount a neutrophilic leukocytosis during pyogenic infection.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 932197      PMCID: PMC436822          DOI: 10.1172/JCI108433

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  24 in total

Review 1.  The complement system of man. I.

Authors:  S Ruddy; I Gigli; K F Austen
Journal:  N Engl J Med       Date:  1972-09-07       Impact factor: 91.245

2.  The C3-activator system: an alternate pathway of complement activation.

Authors:  O Götze; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1971-09-01       Impact factor: 14.307

3.  Additional studies on human C5: development of a modified purification method and characterization of the purified product by polyacrylamide gel electrophoresis.

Authors:  U R Nilsson; R H Tomar; F B Taylor
Journal:  Immunochemistry       Date:  1972-07

4.  Immune hemolysis. I. Differing susceptibility of three genetic types of sheep red cells.

Authors:  D A Bell; P F Leblond; J P Leddy; P K Lauf; P L LaCelle; R I Weed
Journal:  J Immunol       Date:  1972-02       Impact factor: 5.422

5.  Structural polymorphism of the fourth component of human complement.

Authors:  S I Rosenfeld; S Ruddy; K F Austen
Journal:  J Clin Invest       Date:  1969-12       Impact factor: 14.808

6.  C3 inactivator of man. I. Hemolytic measurement by the inactivation of cell-bound C3.

Authors:  S Ruddy; K F Austen
Journal:  J Immunol       Date:  1969-03       Impact factor: 5.422

7.  Role of C5 in the nephritis of NZB-W mice.

Authors:  B G Lanier; F C McDuffie; K E Holley
Journal:  J Immunol       Date:  1971-03       Impact factor: 5.422

8.  Enharncement of the hemolytic activity of the second component of human complement by oxidation.

Authors:  M J Polley; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1967-12-01       Impact factor: 14.307

9.  Heat labile opsonins to pneumococcus. II. Involvement of C3 and C5.

Authors:  H S Shin; M R Smith; W B Wood
Journal:  J Exp Med       Date:  1969-12-01       Impact factor: 14.307

10.  Evidence for linkage between HL-A histocompatibility genes and those involved in the synthesis of the second component of complement.

Authors:  S M Fu; H G Kunkel; H P Brusman; F H Allen; M Fotino
Journal:  J Exp Med       Date:  1974-10-01       Impact factor: 14.307

View more
  30 in total

Review 1.  Genetic loci of components of the classical and alternate pathway of complement activation: a new dimension of the immunogenetic linkage group (HLA) on chromosome 6 in man.

Authors:  C Rittner
Journal:  Hum Genet       Date:  1976-12-29       Impact factor: 4.132

2.  Functions of the complement components C3 and C5 during sepsis.

Authors:  Michael A Flierl; Daniel Rittirsch; Brian A Nadeau; Danielle E Day; Firas S Zetoune; J Vidya Sarma; Markus S Huber-Lang; Peter A Ward
Journal:  FASEB J       Date:  2008-06-27       Impact factor: 5.191

3.  Complement (C5-a)-induced granulocyte aggregation in vitro. A possible mechanism of complement-mediated leukostasis and leukopenia.

Authors:  P R Craddock; D Hammerschmidt; J G White; A P Dalmosso; H S Jacob
Journal:  J Clin Invest       Date:  1977-07       Impact factor: 14.808

4.  Absence of the eighth component of complement in association with systemic lupus erythematosus-like disease.

Authors:  H E Jasin
Journal:  J Clin Invest       Date:  1977-09       Impact factor: 14.808

5.  [Relations between complement and blood coagulation (author's transl)].

Authors:  G Müller-Berghaus
Journal:  Klin Wochenschr       Date:  1977-07-15

6.  Lung defenses against Pseudomonas aeruginosa in C5-deficient mice with different genetic backgrounds.

Authors:  M C Cerquetti; D O Sordelli; J A Bellanti; A M Hooke
Journal:  Infect Immun       Date:  1986-06       Impact factor: 3.441

Review 7.  Lupus diseases associated with hereditary and acquired deficiencies of complement.

Authors:  V Agnello
Journal:  Springer Semin Immunopathol       Date:  1986

Review 8.  Renal disease associated with inherited disorders of the complement system.

Authors:  Thomas R Welch; Lisa W Blystone
Journal:  Pediatr Nephrol       Date:  2008-10-29       Impact factor: 3.714

9.  Protective role of complement in experimental Escherichia coli endocarditis.

Authors:  D T Durack; P B Beeson
Journal:  Infect Immun       Date:  1977-04       Impact factor: 3.441

10.  Genetic studies on experimental autoimmune gastritis induced by neonatal thymectomy using recombinant inbred strains between a high-incidence strain, BALB/c, and a low-incidence strain, DBA/2.

Authors:  Y Mori; M Hosono; K Murakami; H Katoh; Y Yoshikawa; K Kuribayashi; R Kannagi; M Sakai; M Okuma; T Masuda
Journal:  Clin Exp Immunol       Date:  1991-04       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.